Ketamine therapy is often used to help patients undergoing cancer treatments. Ketamine is an antipsychotic drug mainly used for inducing and maintaining fast unconsciousness in patients with brain cancer or severe disabilities that have difficulty moving. It causes a state of amnesia, dissociative sedation, pain relief, and is sometimes referred to as super-hypnotism. It can produce a state of euphoria in patients. In fact, ketamine has been compared to cocaine in the sense that it can produce similar results. Get more informations about California Center for Ketamine Therapy various brands
Ketamine has been used to effectively treat a wide range of psychiatric disorders, including Parkinson’s disease, delusions, psychosis, anxiety and mood disorders. Ketamine has also shown to have a rapid effect on the heart, increasing cardiac output and slowing the rate of arterial dilation in patients with type 1 diabetes. IV infusions of ketamine therapy have been successful in the treatment of intractable epilepsy, dysthymia, attention deficit disorder (ADD) and other mental disorders associated with the nervous system. Ketamine has also shown effective treatment of symptoms of substance abuse, depression, substance withdrawal and nausea and vomiting.
Because of the interest-free financing provided by the US Federal Government and various pharmaceutical companies, ketamine therapy is rapidly gaining popularity among patients seeking a treatment for their illnesses. Ketamine is particularly effective for patients who are undergoing long-term treatment with certain antidepressants. Patients who would not be able to tolerate the traditional antidepressant drugs or who have severe side effects that can only be managed through the use of antiepileptic drugs are good candidates for this new treatment. The Food and Drug Administration (FDA) has approved the use of ketamine therapy in clinical trials for attention deficit disorder, depression, diabetes, epilepsy and schizophrenia. This medical treatment can also be provided to patients who have undergone spinal cord surgery and patients with Parkinson’s disease.